Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia

NCT01025778 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia

Interventions

DRUG: Clofarabine for remission induction
DRUG: Etoposide for remission induction
DRUG: Cyclophosphamide for remission induction
DRUG: Clofarabine in conditioning before transplantation
DRUG: Thiotepa in conditioning before transplantation
DRUG: Melfalan in conditioning before transplantation
PROCEDURE: Haploidentical transplantation of T-cell depleted graft
PROCEDURE: Donor lymphocyte infusion

Sponsor

Lund University Hospital